Key result
Among 3019 colorectal cancer patients, 13% developed peritoneal carcinomatosis, with synchronous disease demonstrating a poor median survival of 7 months.
Population
3019 patients with colorectal cancer from a database, including 349 with peritoneal carcinomatosis.
Design
Cohort
Authors
Loading...
Supports vigilant surveillance for peritoneal spread in colorectal cancer; leaves open effective interventions for synchronous disease.
Cohort (n=3,019)
Peritoneal carcinomatosis occurs in 13% of colorectal cancer patients and carries a poor prognosis with a median survival of 7 months for synchronous disease.
Jayne et al. (2002) conducted a cohort in Peritoneal carcinomatosis from colorectal cancer (n=3,019). Among 3019 colorectal cancer patients, 13% developed peritoneal carcinomatosis, with synchronous disease demonstrating a poor median survival of 7 months.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: